COMT rs4680 and DAOA rs947267 Polymorphism Interact to Influence Cognition and Psychiatric Symptoms in Chronic Schizophrenia
- 15 November 2025
- journal article
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 201 (4) , 300-310
Abstract
Dopaminergic and glutamatergic dysfunction, involving genes such as COMT and DAOA, is implicated in schizophrenia. However, large‐scale studies examining their interactions on cognitive and symptomatic outcomes remain scarce. COMT rs4680 and DAOA rs947267 polymorphisms were measured in chronic schizophrenics ( n = 758) and controls ( n = 416), and cognition and psychiatric symptoms were assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the Positive and Negative Syndrome Scale (PANSS). Both the dominant (OR = 0.582, p = 0.024) and heterozygous (OR = 0.533, p = 0.012) models revealed notable variations in genotype distribution between cases and controls for the COMT polymorphism. Among females, the COMT polymorphism conferred a risk under the recessive model (OR = 1.571, p = 0.045) but a protective effect under heterozygous (OR = 0.378, p = 0.026) and codominant (OR = 0.515, p = 0.005) models. Additionally, we found that the COMT Val and DAOA A alleles interacted synergistically to worsen immediate memory in patients with schizophrenia. A significant COMT × DAOA interaction on language ( p = 0.019) was revealed in schizophrenia but not in controls. Val/Val + A schizophrenia carriers exhibit poorer language performance than Met + A carriers (AA/CA genotypes) ( p = 0.019). Furthermore, Met + CC schizophrenia carriers demonstrated significantly higher PANSS‐G ( p = 0.020) or total PANSS scores ( p = 0.008) than Met + A carriers. These findings, derived from large‐scale empirical data, offer a more profound understanding of the complex regulatory mechanism between the dopamine and glutamate systems regarding cognition and clinical symptoms in chronic schizophrenia. This understanding may lead to the development of more effective treatments targeting both systems.Keywords
Funding Information
- National Natural Science Foundation of China (61673391)
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (Z161100002616017)
This publication has 52 references indexed in Scilit:
- Dopamine and glutamate in schizophrenia: biology, symptoms and treatmentWorld Psychiatry, 2020
- Effects of COMT polymorphisms on brain function and behavior in health and diseaseBrain Research Bulletin, 2012
- HapMap tag-SNP analysis confirms a role forCOMTin schizophrenia risk and reveals a novel associationEuropean Psychiatry, 2012
- Interaction between effects of genes coding for dopamine and glutamate transmission on striatal and parahippocampal functionHuman Brain Mapping, 2012
- Interactive Effects of DAOA (G72) and Catechol-O-Methyltransferase on Neurophysiology in Prefrontal CortexBiological Psychiatry, 2011
- Effect of D‐amino acid oxidase activator (DAOA; G72) on brain function during verbal fluencyHuman Brain Mapping, 2011
- Genetic variation in G72 correlates with brain activation in the right middle temporal gyrus in a verbal fluency task in healthy individualsHuman Brain Mapping, 2010
- Imaging genetics and development: Challenges and promisesHuman Brain Mapping, 2010
- Catechol-o-Methyltransferase, Cognition, and Psychosis: Val158Met and BeyondBiological Psychiatry, 2006
- Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: A large-scale association study plus meta-analysisBiological Psychiatry, 2005